 There's such a large amount of diseases that don't have medicines available for them because we simply have not had the computing power, the opportunity to deploy ourselves. And now we're at this next great revolution in science. Helping change the paradigm is the fact AI can help Sanofi and others in the drug industry conduct research and development far more efficiently, which can bring down costs and help treatments for conditions from which fewer people suffer make more sense financially. From the Bloomberg Newsroom, I'm Andrew O'Day on WTOP.